In brain cells from mice, a protein called FGF21 helps protect against damage caused by lack of oxygen and sugar, and this protection seems to work through a specific cellular switch called AMPK.

What we've found so far suggests that FGF21 may help reduce brain cell damage in mouse neurons when oxygen and sugar are low, and this effect could involve the activation of a cellular pathway called AMPK. Our analysis of the available research shows that in studies using mouse brain cells, FGF21 appears to trigger protective mechanisms during oxygen and nutrient deprivation [1]. The evidence we've reviewed leans toward the idea that FGF21 plays a role in shielding neurons from damage under stressful conditions like low oxygen. In these lab-based experiments, the protective effect of FGF21 seems to depend on AMPK, a protein that acts as a key regulator of cellular energy and survival [1]. When AMPK is activated, it can influence processes that help cells cope with stress, and the data indicate this pathway may be how FGF21 exerts its effect in mouse neurons [1]. So far, we have analyzed one key assertion from the research, and all supporting evidence points in the same direction—seven study references back this mechanism, with none contradicting it [1]. However, this is based on a limited number of assertions and confined to mouse neuronal cells in controlled settings. We cannot say whether this same process happens in living animals or humans, or if other factors may influence the outcome. Our current analysis shows a consistent pattern in the lab studies we’ve reviewed, but the full picture may be more complex. We don’t yet know how strong or reliable this effect is over time, or under different conditions. Practical takeaway: In lab-grown mouse brain cells, FGF21 seems to help protect against oxygen and sugar deprivation, likely by turning on AMPK. But we’re still early in understanding how this might apply beyond these specific experiments.